Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

2.1. Tissue Sample

CW Carl Mathis Wild
FG Fabian Garrido
CD Christian Dannecker
MK Melitta B. Köpke
MC Marie-Christine Chateau
FB Florence Boissière-Michot
HH Helene H. Heidegger
AV Aurelia Vattai
MK Mirjana Kessler
UJ Udo Jeschke
VC Vincent Cavaillès
request Request a Protocol
ask Ask a question
Favorite

For this study, we included formalin fixed paraffin embedded cervical cancer samples of 238 patients (without distant metastasis) who underwent surgery in the years 1993–2002 at the Department of Gynecology and Obstetrics, Ludwig Maximilian University Munich, Germany (see Table 1 for a description of the cohort characteristics). This happened without any preselection. Only patients with tumors corresponding to CSCC and CAC histological subtypes participated in the cohort. The clinical and follow-up data, such as patient age, overall survival (OS), disease-free survival (DFS), lymph node status, tumor size, presence of metastases, histopathological grading, tumor subtype and FIGO 2009 (Fédération Internationale de Gynécologie et d’Obstétrique) stage, were retrieved from the Munich Cancer Registry.

Baseline characteristics for CSCC and CAC samples.

Copyright and License information:  ©2023 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A